Risks for kidney cancer

Last medical review:

Some things can affect your risk, or chance, of developing cancer. Certain behaviours, substances or conditions can increase or decrease the risk. Most cancers are the result of many risks. But sometimes cancer develops in people who donʼt have any risks.

Smoking tobacco is the main risk for kidney cancer. Kidney cancer occurs most often in people older than 60. More men than women develop kidney cancer.

If you have a genetic condition that increases your risk for kidney cancer, you may need to visit your doctor more often. Talk to your doctor about your risk and if you need to have certain tests to check for kidney cancer.

Some of these risks canʼt be changed. But in some cases, there are things you can do to lower your risk.

The following can increase your risk for kidney cancer:

Smoking tobacco

Excess weight

High blood pressure

Genetic conditions

End-stage kidney disease and dialysis

Family history of kidney cancer

Contact with trichloroethylene (TCE) at work

Tall adult height

The following can decrease your risk for kidney cancer:

Moderate alcohol consumption

Smoking tobacco

Smoking tobacco increases your risk for kidney cancer.

The more you smoke and the longer you smoke, the greater your risk. The risk of developing kidney cancer decreases with time after you quit smoking.

Learn more about how to live smoke-free.

Excess weight

Overweight and obesity increase the risk for renal cell carcinoma (RCC), the most common type of kidney cancer.

Learn more about how to have a healthy body weight.

High blood pressure

High blood pressure (hypertension) increases the risk of RCC. Some medicines used to lower blood pressure also increase the risk.

Genetic conditions

A genetic condition is a disease caused by a change (mutation) in one or more genes. Having certain genetic conditions increases the risk of developing different types of cancerous and non-cancerous tumours of the kidney.

People with the following genetic conditions develop kidney cancer at a younger age than other people. These genetic conditions are not very common. They cause only a small number of all kidney cancers.

Von Hippel-Lindau (VHL) syndrome is an inherited condition that makes blood vessels in the eyes, brain, spinal cord, adrenal glands and other parts of the body grow abnormally. VHL increases the risk of developing clear cell RCC.

Hereditary papillary renal carcinoma (HPRC) is an inherited condition in which people develop many papillary RCC tumours in both kidneys.

Hereditary leiomyomatosis renal cell carcinoma (HLRCC) increases the risk of developing non-cancerous tumours called leiomyomas in the skin or uterus. HLRCC also increases the risk of developing papillary RCC type 2.

Birt-Hogg-Dube (BHD) syndrome is a very rare genetic condition that affects the skin and lungs. BHD syndrome increases the risk of cancerous and non-cancerous kidney tumours such as chromophobe RCC and oncocytomas.

Tuberous sclerosis is an inherited condition that causes non-cancerous tumours to develop in the brain, spinal cord, skin, eyes, heart, lungs and kidneys. Tuberous sclerosis increases the risk of neuroendocrine cancer and kidney cancer.

End-stage kidney disease and dialysis

End-stage kidney disease is when the kidneys can no longer remove waste products from the blood, so a person needs a kidney transplant or dialysis. Dialysis is a procedure that takes the place of the kidneys and removes waste products from the blood.

People on dialysis for a long time can develop cysts in their kidneys (acquired cystic kidney disease). Acquired cystic kidney disease in turn increases the risk of kidney cancer. The risk of kidney cancer appears to increase the longer a person is on dialysis.

People who have had a kidney transplant also seem to have a greater chance of developing kidney cancer in the other (non-transplanted) kidney.

Family history of kidney cancer

If you have a first-degree relative who has had kidney cancer, you have an increased risk of developing kidney cancer. The risk is greater if the relative is a brother or sister.

Contact with trichloroethylene (TCE) at work

Trichloroethylene (TCE) is an industrial solvent mainly used to remove grease from metal. It is also sometimes used in dry cleaning. Coming into contact with TCE at work increases the risk for kidney cancer. The risk increases with higher levels of TCE.

Tall adult height

Research shows that the taller a person is, the greater their risk for kidney cancer. It isn’t exactly clear how being tall increases the risk.

Moderate alcohol consumption

Evidence shows that drinking alcohol (up to 2 drinks a day) decreases the risk for kidney cancer. However, itʼs important to remember that there is strong evidence that drinking alcohol increases the risk of at least 9 different types of cancers. Drinking alcohol should not be used to lower the risk for kidney cancer.

To reduce your cancer risk, it’s best not to drink alcohol. Find out more about alcohol and cancer.

Possible risks

The following have been linked with an increased risk of kidney cancer, but more research is needed to know for sure that they are risks:

  • horseshoe kidney (a rare birth defect in which the tissue forming the kidneys does not divide into 2 separate kidneys)
  • polycystic kidney disease
  • kidney stones
  • hepatitis C infection
  • hysterectomy
  • diabetes
  • personal history of thyroid cancer
  • arsenic in drinking water
  • contact with radiation
  • contact with welding fumes or cadmium at work
  • contact with pesticides such as perfluorooctanoic acid (PFOA)
  • regular use of non-steroidal anti-inflammatory drugs (NSAIDs)

Physical activity has been linked with a decreased risk of kidney cancer, but more research is needed to know for sure that it lowers the risk.

Understanding your cancer risk

To make the decisions that are right for you, ask your doctor questions about risks. Learn how cancer can be prevented and what you can do to reduce your risk.

Expert review and references

  • Canadian Cancer Society | Société canadienne du cancer
  • American Cancer Society. Risk Factors for Kidney Cancer. 2024. https://www.cancer.org/.
  • American Institute for Cancer Research, World Cancer Research Fund. Continuous Update Project Report: Diet, Nutrition, Physical Activity and Kidney Cancer. 2015. https://www.aicr.org/research/the-continuous-update-project/.
  • Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. Giornale Italiano di Nefrologia. 2022: 39(3):2022-vol3.
  • Cancer Research UK. Risks and Causes of Kidney Cancer. 2024. https://www.cancerresearchuk.org/.
  • Chow WH, Scelo G, Tarone RE. Renal cancer. Thun MJ, Linet MS, Cerhan JR, Haiman CA Schottenfeld D, eds.. Schottenfeld and Fraumeni Cancer Epidemiology and Prevention. 4th ed. New York, NY: Oxford University Press; 2018: 51.
  • Correa AF, Rini BI, Linehan WM, Schmidt LS, Lane BR, Uzzo RG. Cancer of the kidney. DeVita VT Jr, Lawrence TS, Rosenberg S. eds. DeVita Hellman and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. Philadelphia, PA: Wolters Kluwer; 2023: Kindle version, 43, https://read.amazon.ca/?asin=B0BG3DPT4Q&language=en-CA.
  • Bellini MI, Lori E, Forte F. Thyroid and renal cancers: A bidirectional association. Frontiers in Oncology. 2022: 12:951976.
  • International Agency for Research on Cancer (IARC). Volume 135: Perfluorooctanoic acid (PFOA) and Perfluorooctanesulfonic acid (PFOS) . 2025.
  • International Agency for Research on Cancer (IARC). Volume 130:1,1,1-Trichloroethane and Four Other Industrial Chemicals. 2022.
  • International Agency for Research on Cancer (IARC). IARC Monographs on the Idenification of Carcinogenic Hazards to Humans Volume 100E: Personal Habits and Indoor Combustions. 2012.
  • Jung M, Li M, Shin J, et al. Association between antihypertensive medication use and kidney cancer risk: a meta-analysis accounting for hypertension. BMC Cancer. 2025: 25(1):1013.
  • Chaker K, Gharbia N, Ouane Y, et al. Renal cell carcinoma in a horseshoe kidney: A case report. International Journal of Surgery Case Reports. 2025: 128:111015.
  • Malyszko J, Tesarova P, Capasso G, Capasso A. The link between kidney disease and cancer: complications and treatment. Lancet. 2020: 396(10246):277-287.
  • Matthews CE, Moore SC, Arem H, et al. Amount and intensity of leisure-time physical activity and lower cancer risk. Journal of Clinical Oncology. 2020: 38(7):686-697.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Kidney Cancer Version 1.2026. 2025.
  • National Toxicology Program. Report on Carcinogens. 15 ed. Research Triangle Park, NC: US Department of Health and Human Services, Public Health Service; 2021. https://ntp.niehs.nih.gov/whatwestudy/assessments/cancer/roc/index.html.
  • Park YH, Moon HW, Cho HJ, et al. Cumulative obesity exposure increases the risk of kidney cancer: a longitudinal nationwide cohort study. American Journal of Cancer Research. 2021: 11(10):5016-5026.
  • Yanus GA, Kuligina ES, Imyanitov EN. Hereditary renal cancer syndromes. Med Sci (Basel). 2024: 12(1):12.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society